The Modified EIF2S Peptide sequence (Modified-CILLSELSRRRIR) is derived from human EIF2S1 (46-57) and is suitable for use as the substrate for EIF2AK kinase family and MNK1.
Catalog No. E23-58B
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| E23-58B | 1 mg | $105 | |
| E23-58B-BULK | BULK | Contact Us |
No overview information available.
Purity:
The purity was determined to be 95.88% by HPLC analysis.
Storage, Stability and Shipping:
Store product at –20oC. For optimal storage, aliquot diluted product into smaller quantities and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
1614.99
JB Bell et al., Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy is Regulated by MNK1 and mRNA Translation Mol Cancer Res October 2017 10.1158/1541-7786.MCR-17-0397
B Bell Jonathan et al., Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy is Regulated by MNK1 and mRNA Translation Mol Cancer res 10.1158/1541-7786.MCR-17-0397
Angiogenesis, Cellular Stress, Inflammation, Neurobiology, Ser/Thr Kinases
MNK1, Active, M54-10G
EIF2AK2, Active, P80-11G
EIF2AK3, Active, E11-11G
EIF2AK4 (GCN2), Active, E12-11G
STAY CONNECTED
Fax: 1-604-232-4601
Toll Free: 1-866-954-6273
info@signalchem.com